MIT research shows positive results of skin patch for cancer treatment
By Nikita Chaurasia  Date: 2019-08-26

MIT research shows positive results of skin patch for cancer treatment
  • The skin patch designed, demonstrated positive results in an experiment on mice and human skin samples.
  • The MIT researchers designed the patch to fight melanoma cancer.

Researchers at the Massachusetts Institute of Technology reportedly announced successful results of a skin patch developed to offer cancer treatment in mice & human skin samples at the American Chemical Society conference in California, San Diego.

Apparently, the researchers at the MIT designed the patch to fight melanoma, a fatal but treatable skin cancer. For the uninitiated, Melanoma is subjected to be caused by an extreme exposure to UV rays from the sun or other sources. It has been claimed that the patch is less than a centimeter long and covered with a gluey film, which allows it to be applied and detached from the skin within a minute.

As per trusted reports, the researchers of the organization used the patch to deliver a toxin in healthy mice and later compared the immune response to other treatment methods used to vaccinate against the flu and measles. The results of the skin patch presented a robust antibody response along with a strong immune response in human skin.

The lead author of the study and HOD of Chemical Engineering, MIT, Dr. Paula Hammond reportedly stated that the organization’s recently designed patch technology can be used to offer vaccines to fight against various infectious diseases. Additionally, the researchers are pleased by the possibility of the patch to win against melanoma cancer.

The patch is embedded with microneedles, developed through a layer-by-layer coating process. This provides the advantage over syringes for its painless, easy to administer and reduced infection risk characteristics.

The researchers claimed that the patch treatment produced over 9 times the level of infection-fighting antibodies while comparing to the intramuscular injections. Additionally, it also produced over 160 times the level of antibodies compared to subcutaneous injections.

Speculation has it that the research was aided by the U.S. Department of Defense along with the Koch Institute for Integrative Cancer Research at MIT and Singapore-MIT Alliance for Research and Technology.

Source credit: https://www.cnbc.com/2019/08/25/new-skin-patch-to-deliver-cancer-medicine-shows-promise-in-mice-mit-scientists-say.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Coinbase puts forth a buyout offer for crypto brokerage firm Tagomi
Coinbase puts forth a buyout offer for crypto brokerage firm Tagomi
By Nikita Chaurasia

San Francisco based digital currency exchange major Coinbase has reportedly announced its acquisition of the crypto prime brokerage platform, Tagomi. For eight years, Coinbase has been known for its credibility in the field of industry-leading tradin...

National Congress of China recommends government-led blockchain fund
National Congress of China recommends government-led blockchain fund
By Nikita Chaurasia

The parliament of China, National People’s Congress, has reportedly given a suggestion for a blockchain development fund, backed by the government to be able to build up a good governance system. The most powerful and important political adviso...

Halifax to initiate COVID-19 vaccine trials with CanSino Biologics
Halifax to initiate COVID-19 vaccine trials with CanSino Biologics
By Nikita Chaurasia

The Dalhousie University, also known as Halifax University, located in Canada, has reportedly announced that its team would be working in collaboration with Chinese manufacturer, CanSino Biologics, to conduct the first-ever Canadian clinical trial fo...

Researchers to investigate the risk of airborne viruses in buildings
Researchers to investigate the risk of airborne viruses in buildings
By Nikita Chaurasia

As the world gradually paces back to normalcy after recuperating from the devastating effects of COVID-19, a research team from DOE’s Lawrence Berkeley National Laboratory (Berkeley Lab) embarked on the quest to study the risk of airborne virus...

NZME unveils a takeover bid of US$0.61 for its rival Stuff Limited
NZME unveils a takeover bid of US$0.61 for its rival Stuff Limited
By Nikita Chaurasia

NZME, a News Zealand media giant, has recently unveiled a symbolic US$0.61 (NZ$1) takeover bid for rival Stuff Limited in an attempt for consolidation of the news industry in the country, amid the downturn caused by the coronavirus pandemic. Nine Ent...